Pralidoxime

National DefenceDrugs and Pharmaceutical Products
☆ Save tender
Published
Closing Date
Region
Africa

Description

NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to chemical warfare agents. The initial requirement is for the delivery of 450 doses to be delivered before 31 March 2027. Optional requirements of 600 doses to be requested and delivered between 01 April 2027 and 31 March 2031. There are no security requirements associated with this requirement. The Crown retains the rights to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner.

Bid / no-bid fit

Sign in to see how well this tender fits your company, with reasons.

Tender brief & compliance checklist

A brief has not been generated yet for this tender.

Solicitation documents (1)

Links go to the official files. Search the text of all indexed tender documents: document search

Price benchmark

Range $4,000 – $218.2M · median $1.8M · n=94 · inferred from published winners in the same codes/department

Incumbency

Inferred rotating winners. Top published winner SANOFI PASTEUR LIMITED/SANOFI PASTEUR LIMITEE has 9% of 99 similar awards.

Department buying calendar

JFMAMJJASOND

March highlighted (Canadian fiscal year-end). Spike not the peak month in this dataset.

Run an AI tender pre-check →

Buyer contact (contracting authority)

Stephen Brown · stephen.brown2@forces.gc.ca · (343) 630-0031

Ottawa, Ontario · Competitive - Open bidding

As published on the CanadaBuys tender notice. Use for questions about this solicitation only.

Official Documents & Links

To submit a bid, you must respond through the official government procurement system.

Likely Competitors

Companies that won similar contracts (same category/department). Inferred from public award data — winners only.

Bavarian Nordic A/S

Won 4 similar contracts worth $34,830,923.1

$34,830,923.1
4 contracts
Merck Canada Inc.

Won 6 similar contracts worth $283,611,072.15

$283,611,072.15
6 contracts
SANOFI PASTEUR LIMITED/SANOFI PASTEUR LIMITEE

Won 9 similar contracts worth $196,994,848.24

$196,994,848.24
9 contracts
Moderna Biopharma Canada Corporation

Won 1 similar contracts worth $160,635,561.65

$160,635,561.65
1 contracts
Pfizer Canada ULC

Won 3 similar contracts worth $114,354,630.52

$114,354,630.52
3 contracts
Emergent Product Development Gaithersburg Inc

Won 3 similar contracts worth $107,328,004.01

$107,328,004.01
3 contracts
Emergent BioSolutions Canada Inc.

Won 7 similar contracts worth $53,667,854.78

$53,667,854.78
7 contracts
Seqirus Canada Inc

Won 3 similar contracts worth $49,068,610.76

$49,068,610.76
3 contracts
GlaxoSmithKline Inc.

Won 9 similar contracts worth $48,865,590.72

$48,865,590.72
9 contracts
Elusys Therapeutics, Incorporated

Won 1 similar contracts worth $45,712,664.4

$45,712,664.4
1 contracts